港股異動 | 恆騰網絡(0136.HK)反彈超7% 《你好,李煥英》進入全球票房前100且延長上映時間
格隆匯3月10日丨恆騰網絡(0136.HK)盤中一度衝高超14%,現報9.17港元,漲幅收窄至7.63%,總市值847億港元。近期股價自高位回撤超40%。恆騰網絡旗下儒意影業為《你好,李煥英》主要出品方和最大保底發行方。截至3月10日,《你好,李煥英》的票房為7.83億美元(約51億元人民幣),已正式躋身全球單片票房排行榜的前一百名。另外,日前《你好,李煥英》宣佈密鑰延期,將延長上映至2021年4月11日。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.